Page 5 - HFA_Dateline_2019_Q2_Summer
P. 5
Creating the path for
advancements in hemophilia
gene therapy research
Join us at
HemophiliaForward.com
Spark Therapeutics has created For residents of the U.S. only
a place for patients and caregivers
TO LEARN ABOUT THE SCIENCE OF
GENE THERAPY RESEARCH, which
is being investigated for hemophilia.
“It is incredible to think of what a transformative “My career has been focused on delivering
advance gene therapy could be—it has been cutting-edge medical care for patients with
my career focus for the past two decades hemophilia. I’m excited that gene therapy
to solve this challenge.” could potentially be brought to people I have
cared deeply about for so many years.”
Katherine A. High, MD, president and chief scientific o cer
Leonard Valentino, MD, medical strategy lead, hematology
© 2018 Spark Therapeutics, Inc.
Hemophilia Forward is sponsored by Spark Therapeutics, Inc.
1-855-SPARKTX
N-HEM-US-420016